|
Paterns of Failure in Uterine Leiomyosarcoma. |
|
|
Speakers' Bureau - Taiho Pharmaceutical |
|
|
|
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda; Yakult Honsha |
Research Funding - Chugai Pharma (Inst); Otsuka (Inst); Yakult Honsha (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ajinomoto; Astellas Pharma; Daiichi Sankyo; Eisai; Ono Pharmaceutical; TERUMO |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |